Share chart Adlai Nortye Ltd. American Depositary Shares
Extended chart
Simple chart
About Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. more details| IPO date | 2023-09-29 |
|---|---|
| ISIN | US00704R1095 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.adlainortye.com |
| Цена ао | 2.2 |
| Change price per day: | 0% (2.09) |
|---|---|
| Change price per week: | +5.56% (1.98) |
| Change price per month: | -7.11% (2.25) |
| Change price per 3 month: | +2.96% (2.03) |
| Change price per half year: | +7.18% (1.95) |
| Change price per year: | -80.15% (10.53) |
| Change price per year to date: | -5.85% (2.2199) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Millennium Management LLC | 30000 | 0.1 |
| Cantor Fitzgerald, L. P. | 17666 | 0.06 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Yang Lu | CEO & Chairman | N/A | 1981 (44 years) |
| Ms. Wei Zhang | Chief Financial Officer | N/A | 1992 (33 years) |
| Dr. Kaiyang Tang | President | N/A | 1965 (60 years) |
| Dr. Victoria Elizabeth Demby Ph.D. | Senior VP & Global Head of Regulatory Affairs | N/A | 1971 (54 years) |
| Dr. Ngai Chiu Tse M.D., Ph.D. | Head of Research & Development | N/A | 1968 (57 years) |
Address: Cayman Islands, Grand Cayman KY-, Ugland House - open in Google maps, open in Yandex maps
Website: https://www.adlainortye.com
Website: https://www.adlainortye.com
